X0306 4 2019-04-01 0 0001410939 Ophthotech Corp. OPHT 0001277478 SBLENDORIO GLENN C/O OPHTHOTECH CORPORATION ONE PENN PLAZA, 35TH FLOOR NEW YORK NY 10119 1 1 0 0 President and CEO Common Stock 2019-04-01 4 M 0 18750 A 75019 D Common Stock 2019-04-02 4 S 0 6914 1.43 D 68105 D Restricted Stock Units 2019-04-01 4 M 0 18750 0.00 D 2026-03-31 Common Stock 18750 18750 D Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units. This total includes 3,078 shares acquired by the reporting person on September 15, 2018 under the issuer's 2016 Employee Stock Purchase Plan and 4,734 shares acquired by the reporting person on March 15, 2019 under the issuer's 2016 Employee Stock Purchase Plan. This total has also been increased by 50 shares to correct a scrivener's error in the amount of securities reported as beneficially owned by the reporting person on the Form 4 filed on April 4, 2017. Represents shares automatically sold pursuant to the prespecified terms of the reporting person's Restricted Stock Unit Agreement to satisfy the reporting person's minimum statutory withholding obligations with respect to the income recognized by the reporting person upon the vesting of the restricted stock units on April 1, 2019. On April 1, 2016, the reporting person was granted an award of 75,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan. /s/ Todd Anderman, as Attorney-in-Fact for Glenn P. Sblendorio 2019-04-03